Assenagon Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.6K | Hold |
46,842
| – | – | ﹤0.01% | 1115 |
|
|
2025
Q1 | $156K | Sell |
46,842
-1,700,035
| -97% | -$5.66M | ﹤0.01% | 1102 |
|
|
2024
Q4 | $12.9M | Buy |
+1,746,877
| New | +$12.9M | 0.02% | 425 |
|
|
2023
Q3 | – | Sell |
-32,047
| Closed | -$226K | – | 1372 |
|
|
2023
Q2 | $226K | Hold |
32,047
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q1 | $196K | Sell |
32,047
-7
| -0% | -$43 | ﹤0.01% | 1324 |
|
|
2022
Q4 | $205K | Sell |
32,054
-65
| -0.2% | -$416 | ﹤0.01% | 1258 |
|
|
2022
Q3 | $308K | Hold |
32,119
| – | – | ﹤0.01% | 1153 |
|
|
2022
Q2 | $355K | Sell |
32,119
-82
| -0.3% | -$906 | ﹤0.01% | 1248 |
|
|
2022
Q1 | $536K | Hold |
32,201
| – | – | ﹤0.01% | 1142 |
|
|
2021
Q4 | $615K | Sell |
32,201
-1,425,107
| -98% | -$27.2M | ﹤0.01% | 1114 |
|
|
2021
Q3 | $35.9M | Sell |
1,457,308
-22,411
| -2% | -$553K | 0.11% | 127 |
|
|
2021
Q2 | $38.5M | Buy |
1,479,719
+1,443,340
| +3,968% | +$37.6M | 0.13% | 116 |
|
|
2021
Q1 | $1.15M | Buy |
+36,379
| New | +$1.15M | ﹤0.01% | 861 |
|